Fragmentomics

1

Review clinical trials related to Fragmentomics. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Noninvasive Detection of Lung Nodule Malignancy Using cfDNA Fragmentomics

The goal of this observational study is to learn if cfDNA fragmentomics can noninvasively diagnose whether lung nodules are benign or malignant in adults with imaging-detected lung nodules.

Participants needed: 240
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Baohui HanUpdated: Feb 10, 2026Locations: 1Duration: 1 Month
Eligibility criteria

Age ≥ 18 years; [+4]

Pregnant or breastfeeding; [+4]